ENTITY
Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX UW)

4
Analysis
Health Care • United States
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves healthcare sector worldwide.
more
bullish•S&P 500 INDEX
•28 Nov 2019 06:30

U.S. Equity Strategy: Upgrading Health Care to Overweight

Ongoing bullish developments continue to support our belief that we are in the early stages of a broad-based advance following a nearly 2-year...

Logo
478 Views
Share
bullish•S&P 500 INDEX
•06 Nov 2019 05:30

U.S. Equity Strategy: Small-Caps Testing Critical Resistance; Downgrading Communications

As bullish developments pile up, the weight-of-the-evidence continues to support our belief that we may be in the early stages of a broad-based...

Logo
500 Views
Share
bearish•S&P 500 INDEX
•09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
645 Views
Share
bullish•S&P 500 INDEX
•31 Aug 2018 20:26

Vital Signs: Actionable U.S. Stocks

Key Points: Consumer Discretionary retailers and restaurants continue to demonstrate leadership characteristics. Many are breaking to new price and...

Logo
547 Views
Share
bullish•S&P 500 INDEX
•20 Sep 2017 22:37

Vermilion Macro Vision - U.S. Equity Strategy: Sector Commentaries with Recommendations

Our last strategy “Fake Moves” highlighted our view that the markets were showing no parallel to the “fake news” narrative and indeed provided a...

Logo
501 Views
Share
x